Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,400 | 4 | 57.2% |
| Food and Beverage | $1,047 | 43 | 42.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medimetriks Pharmaceuticals, Inc. | $1,773 | 22 | $0 (2023) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $198.64 | 7 | $0 (2020) |
| Journey Medical Corporation | $147.36 | 3 | $0 (2021) |
| Abbott Laboratories | $121.06 | 1 | $0 (2019) |
| Exeltis, USA Inc. | $71.77 | 4 | $0 (2018) |
| Sebela Pharmaceuticals Inc. | $64.19 | 5 | $0 (2022) |
| Glenmark Therapeutics Inc. | $23.00 | 2 | $0 (2019) |
| EPI Health, LLC | $20.35 | 1 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $16.27 | 1 | $0 (2017) |
| Cipher Pharmaceuticals US LLC | $10.99 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $700.00 | 2 | Medimetriks Pharmaceuticals, Inc. ($700.00) |
| 2022 | $11.92 | 1 | Sebela Pharmaceuticals Inc. ($11.92) |
| 2021 | $286.69 | 8 | Medimetriks Pharmaceuticals, Inc. ($157.48) |
| 2020 | $464.52 | 6 | Medimetriks Pharmaceuticals, Inc. ($413.70) |
| 2019 | $711.06 | 13 | Medimetriks Pharmaceuticals, Inc. ($439.38) |
| 2018 | $127.01 | 7 | Ortho Dermatologics, a division of Bausch Health US, LLC ($38.35) |
| 2017 | $145.45 | 10 | Exeltis, USA Inc. ($55.37) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2023 | Medimetriks Pharmaceuticals, Inc. | Neo-Synalar (Drug) | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: Dermatology | ||||||
| 02/21/2023 | Medimetriks Pharmaceuticals, Inc. | Neo-Synalar (Drug) | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: Dermatology | ||||||
| 12/21/2022 | Sebela Pharmaceuticals Inc. | PRAMOSONE (Drug), NAFTIN | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: DERMATOLOGY - TOPICAL CORTICOSTEROIDANSTHETIC | ||||||
| 11/02/2021 | Journey Medical Corporation | — | Food and Beverage | In-kind items and services | $114.21 | General |
| 07/02/2021 | Medimetriks Pharmaceuticals, Inc. | Ketodan (Drug), Neo-Synalar | Food and Beverage | In-kind items and services | $34.53 | General |
| Category: Dermatology | ||||||
| 06/18/2021 | Medimetriks Pharmaceuticals, Inc. | Clindacin ETZ (Drug), Ketodan, Neo-Synalar | Food and Beverage | In-kind items and services | $29.46 | General |
| Category: Dermatology | ||||||
| 05/26/2021 | Medimetriks Pharmaceuticals, Inc. | Clindacin ETZ (Drug), Neo-Synalar | Food and Beverage | In-kind items and services | $33.60 | General |
| Category: Dermatology | ||||||
| 04/28/2021 | Medimetriks Pharmaceuticals, Inc. | Clindacin ETZ (Drug), Ketodan | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Dermatology | ||||||
| 02/24/2021 | Medimetriks Pharmaceuticals, Inc. | Ketodan (Drug), Loprox, Neo-Synalar | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Dermatology | ||||||
| 02/17/2021 | Journey Medical Corporation | TargaDox (Drug), Exelderm, Ximino | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Dermatology | ||||||
| 01/20/2021 | Medimetriks Pharmaceuticals, Inc. | Ciclodan (Drug), Clindacin ETZ, Ketodan | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Dermatology | ||||||
| 12/09/2020 | Medimetriks Pharmaceuticals, Inc. | Clindacin ETZ (Drug), Genadur, Neo-Synalar | Food and Beverage | In-kind items and services | $46.10 | General |
| Category: Dermatology | ||||||
| 09/08/2020 | Medimetriks Pharmaceuticals, Inc. | Clindacin ETZ (Drug), Genadur, Neo-Synalar | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: Dermatology | ||||||
| 08/31/2020 | Journey Medical Corporation | TargaDox (Drug), Exelderm, Ximino | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Dermatology | ||||||
| 06/04/2020 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: PODIATRY | ||||||
| 01/29/2020 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: PODIATRY | ||||||
| 01/13/2020 | Medimetriks Pharmaceuticals, Inc. | Genadur (Drug), Ketodan | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Dermatology | ||||||
| 12/11/2019 | Abbott Laboratories | Supera peripheral stent system (Device) | Food and Beverage | In-kind items and services | $121.06 | General |
| Category: Vascular | ||||||
| 12/10/2019 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: PODIATRY | ||||||
| 11/07/2019 | Medimetriks Pharmaceuticals, Inc. | Loprox (Drug), Clindacin ETZ | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Dermatology | ||||||
| 10/07/2019 | Medimetriks Pharmaceuticals, Inc. | Neo-Synalar, Beser | Food and Beverage | In-kind items and services | $17.18 | General |
| 08/29/2019 | Medimetriks Pharmaceuticals, Inc. | Clindacin ETZ (Drug), Loprox | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Dermatology | ||||||
| 08/28/2019 | Glenmark Therapeutics Inc. | Ecoza (Drug) | Food and Beverage | Cash or cash equivalent | $14.00 | General |
| Category: AntiFungal | ||||||
| 07/08/2019 | Glenmark Therapeutics Inc. | Mupirocin Cream (Drug) | Food and Beverage | Cash or cash equivalent | $9.00 | General |
| Category: Topical Antibiotic | ||||||
| 04/11/2019 | Ortho Dermatologics, a division of Bausch Health US, LLC | BRYHALI (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,084 | 2,628 | $190,069 | $133,430 |
| 2022 | 12 | 945 | 2,256 | $164,853 | $115,690 |
| 2021 | 11 | 1,038 | 2,415 | $181,603 | $129,246 |
| 2020 | 7 | 889 | 2,101 | $146,788 | $98,058 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 574 | 1,608 | $107,398 | $76,033 | 70.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 43 | 138 | $19,717 | $13,004 | 66.0% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 80 | 282 | $14,700 | $10,539 | 71.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 146 | 146 | $12,761 | $9,000 | 70.5% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2023 | 37 | 112 | $11,236 | $8,170 | 72.7% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 77 | 77 | $7,097 | $5,564 | 78.4% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 27 | 64 | $6,230 | $3,875 | 62.2% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2023 | 24 | 52 | $4,567 | $3,084 | 67.5% |
| 11720 | Removal of fingernails or toenails, 1-5 nails | Office | 2023 | 18 | 64 | $2,606 | $1,789 | 68.7% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 11 | 29 | $1,758 | $1,048 | 59.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 28 | 35 | $994.18 | $696.64 | 70.1% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 19 | 21 | $1,004 | $627.95 | 62.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 520 | 1,347 | $93,809 | $65,660 | 70.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 40 | 125 | $17,862 | $12,653 | 70.8% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 102 | 316 | $17,011 | $12,022 | 70.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 126 | 126 | $11,424 | $7,594 | 66.5% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2022 | 36 | 107 | $10,643 | $7,575 | 71.2% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2022 | 19 | 41 | $3,583 | $2,548 | 71.1% |
| 11720 | Removal of fingernails or toenails, 1-5 nails | Office | 2022 | 25 | 84 | $3,449 | $2,420 | 70.2% |
| 99334 | Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | Office | 2022 | 19 | 35 | $2,442 | $1,926 | 78.8% |
| 99348 | Established patient home visit, typically 25 minutes | Office | 2022 | 11 | 26 | $2,510 | $1,828 | 72.8% |
| 99324 | New patient custodial care facility, group care, or assisted living visit, typically 20 minutes | Office | 2022 | 11 | 11 | $722.89 | $545.31 | 75.4% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2022 | 17 | 18 | $817.98 | $541.13 | 66.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 19 | 20 | $579.23 | $377.93 | 65.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 550 | 1,529 | $103,335 | $74,550 | 72.1% |
About Dr. Robert Irwin, DPM
Dr. Robert Irwin, DPM is a Podiatrist healthcare provider based in Merrick, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093760753.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Irwin, DPM has received a total of $2,447 in payments from pharmaceutical and medical device companies, with $700.00 received in 2023. These payments were reported across 47 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($1,400).
As a Medicare-enrolled provider, Irwin has provided services to 3,956 Medicare beneficiaries, totaling 9,400 services with total Medicare billing of $476,425. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Podiatrist
- Location Merrick, NY
- Active Since 05/23/2006
- Last Updated 07/08/2007
- Taxonomy Code 213E00000X
- Entity Type Individual
- NPI Number 1093760753
Products in Payments
- Neo-Synalar (Drug) $1,060
- Clindacin ETZ (Drug) $500.58
- Supera peripheral stent system (Device) $121.06
- LUZU (Drug) $93.15
- Ecoza (Drug) $85.77
- JUBLIA (Drug) $66.10
- Genadur (Drug) $66.07
- NAFTIN (Drug) $52.27
- Ketodan (Drug) $50.98
- Loprox (Drug) $44.35
- LUZU LULICONAZOLE (Drug) $38.35
- TargaDox (Drug) $33.15
- Bensal HP (Drug) $20.35
- Ciclodan (Drug) $19.62
- BRYHALI (Drug) $17.31
- Loprox Cream Kit (Drug) $13.99
- PRAMOSONE (Drug) $11.92
- NUVAIL (Device) $10.99
- Mupirocin Cream (Drug) $9.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.